These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9407171)

  • 1. Efficacy and safety of stand-up irradiation cubicles with UVA metal-halide lamps (and a new filter) or UVA fluorescent lamps for photochemotherapy of psoriasis.
    Calzavara-Pinton PG
    Dermatology; 1997; 195(3):243-7. PubMed ID: 9407171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The action spectrum between 320 and 400 nm for clearance of psoriasis by psoralen photochemotherapy.
    Farr PM; Diffey BL; Higgins EM; Matthews JN
    Br J Dermatol; 1991 May; 124(5):443-8. PubMed ID: 2039720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modified dosage schedule for increased efficiency in PUVA treatment of psoriasis.
    Carabott FM; Hawk JL
    Clin Exp Dermatol; 1989 Sep; 14(5):337-40. PubMed ID: 2612036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
    Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
    J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of psoralen-UVB and psoralen-UVA photochemotherapy in the treatment of psoriasis.
    de Berker DA; Sakuntabhai A; Diffey BL; Matthews JN; Farr PM
    J Am Acad Dermatol; 1997 Apr; 36(4):577-81. PubMed ID: 9092744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal phototoxic dose (MPD) measurements for topical photochemotherapy using a semiautomated MPD tester.
    Al-Ismail D; Edwards C; Al-Ofi O; Anstey AV
    Br J Dermatol; 2013 Sep; 169(3):687-9. PubMed ID: 23607709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
    Collins P; Wainwright NJ; Amorim I; Lakshmipathi T; Ferguson J
    Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [UV irradiation devices for the treatment of psoriasis. Desirable spectra and various criteria for selection].
    Wiskemann A
    Z Hautkr; 1984 Apr; 59(7):449-54. PubMed ID: 6730609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental UVA radiation and eye protection during PUVA therapy.
    Morison WL; Strickland PT
    J Am Acad Dermatol; 1983 Oct; 9(4):522-5. PubMed ID: 6630614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of psoralen - UVA photochemotherapy versus narrow band UVB phototherapy in the treatment of psoriasis.
    Tahir R; Mujtaba G
    J Coll Physicians Surg Pak; 2004 Oct; 14(10):593-5. PubMed ID: 15456547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
    Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
    Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative efficacy of 335 and 365 nm radiation in photochemotherapy of psoriasis.
    Brücke J; Tanew A; Ortel B; Hönigsmann H
    Br J Dermatol; 1991 Apr; 124(4):372-4. PubMed ID: 2025558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of plaque-type psoriasis with cream-PUVA therapy].
    Steinmeyer K; Grundmann-Kollmann M; Podda M; Kaufmann R
    Hautarzt; 2001 Oct; 52(10):885-7. PubMed ID: 17690819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
    Cox NH; Farr PM; Diffey BL
    Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-side comparison of erythemogenic versus suberythemogenic UVA doses in oral photochemotherapy of psoriasis.
    Tanew A; Ortel B; Hönigsmann H
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):408-13. PubMed ID: 10459114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of twice-weekly MPD-PUVA and three times-weekly skin typing-PUVA regimens for the treatment of psoriasis.
    Buckley DA; Healy E; Rogers S
    Br J Dermatol; 1995 Sep; 133(3):417-22. PubMed ID: 8546997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PUVA therapy for psoriasis: choosing a suitable régime.
    Samuel M; Henry RW; Allen GE; Kelly AM
    Ulster Med J; 1985 Oct; 54(2):196-9. PubMed ID: 4095810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis.
    Calzavara-Pinton PG; Ortel B; Hönigsmann H; Zane C; De Panfilis G
    Dermatology; 1994; 189(3):256-9. PubMed ID: 7949478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of 8-methoxypsoralen kinetics: a relevant factor in the treatment of psoriasis by psoralen plus ultraviolet A therapy.
    Bonnot D; Béani JC; Boitard M; Reymond JL; Bériel H; Amblard P
    Photodermatol Photoimmunol Photomed; 1994 Feb; 10(1):33-7. PubMed ID: 8180098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of turbo-PUVA and conventional American-style PUVA in the treatment of psoriatic patients.
    Moneib HA; Salem SA; Younis RM
    Photodermatol Photoimmunol Photomed; 2010 Aug; 26(4):205-10. PubMed ID: 20626823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.